Jardiance 10 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DR26F5UYQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,498
Award facts
- Contract value 100% obligated
- $34,498.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Jardiance 10 mg tablets in a 90-count quantity. This firm fixed-price delivery order, valued at $34,498.06, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999.9 million ceiling through December 2026. The contract was competitively awarded with no set-aside designation and is scheduled for completion by November 6, 2025. Performance will occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies critical medications and medical commodities to support military and federal healthcare systems. Jardiance, a diabetes management medication, falls within the company's extensive portfolio of brand-name and generic pharmaceuticals delivered through the DLA's Medical Supply Chain. As a prime vendor under the Pharmaceutical Prime Vendor Global Program, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities, demonstrating its established capability to fulfill federal medical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F5UYQ?
SPE2DR26F5UYQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26F5UYQ worth?
The government has obligated $34,498 on SPE2DR26F5UYQ.
Is contract SPE2DR26F5UYQ an order under another contract?
Yes. SPE2DR26F5UYQ is a delivery order under SPE2DR25D2105, an indefinite delivery contract.
Was contract SPE2DR26F5UYQ competed?
The extent of competition for SPE2DR26F5UYQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award